Research Article
Analysis of Surgical Site Infection after Musculoskeletal Tumor Surgery: Risk Assessment Using a New Scoring System
Table 2
Analysis of risk factors for surgical site infection in malignant bone and soft tissue tumors.
| | | Non-SSI () | SSI () | Odds ratio | 95% CI | value |
| | Age | | | | | 0.40 | | Aged case (>60 y) | 73 (53.3%) | 12 (66.7%) | 1.62 | 0.57–4.57 | 0.36 | Gender
(male/female) | 66/63 | 6/12 | 0.48 | 0.16–1.35 | 0.16 | | BMI (kg/m2) | | | | | 0.20 | | Overweight (>25) | 40 (31.0%) | 7 (38.9%) | 1.41 | 0.51–3.92 | 0.50 | | Hypertension | 32 (25%) | 6 (33.0%) | 1.51 | 0.53–4.37 | 0.44 | | Ischemic heart disease | 4 (3.1%) | 4 (22.2%) | 10.4 | 2.31–47.0 | 0.001 | | Diabetes | 15 (11.6%) | 2 (11.1%) | 0.95 | 0.19–4.54 | 0.95 | Tumor location
(Trunk/Extremity) | 14/111 | 4/14 | 1.76 | 0.52–5.95 | 0.36 | | Primary/metastatic tumor | 110/19 | 15/3 | 1.15 | 0.30–4.38 | 0.99 | | Preoperative chemotherapy | 12 (9.3%) | 6 (33.3%) | 4.87 | 1.55–15.3 | 0.003 | | Skin incision (cm) | | | | | 0.04 | | Large skin incision (>25 cm) | 41 (31.8%) | 10 (55.6%) | 2.68 | 0.68–5.0 | 0.047 | | Use of artificial materials | 34 (26.4%) | 10 (55.6%) | 3.49 | 1.27–9.58 | 0.01 | | Reconstructive procedure | 42 (32.6%) | 6 (33.3%) | 1.04 | 0.37–2.95 | 0.95 | | Secondary wound closure | 25 (19.4%) | 3 (16.7%) | 0.83 | 0.22–3.10 | 0.78 | | Duration of surgery (min) | | | | | 0.0002 | | Prolonged surgery (≥355 min) | 32 (24.8%) | 12 (66.7%) | 6.06 | 2.10–17.4 | 0.0003 | | Blood loss (g) | | | | | 0.0005 | | Massive blood loss (≥190 g) | 23 (17.4%) | 9 (50.0%) | 4.39 | 1.47–13.0 | 0.005 |
|
|
